The FHIT gene is disrupted by the t(3;8) chromosomal ern blotting and showed rearranged BamHI fragments.
translocation observed in a family with renal cell carciThese data suggest a critical role of the FHIT gene in noma and contains the FRA3B fragile site and the target lung carcinogenesis.
of homozygous deletions in various human cancer-derived cell lines. Moreover, the study by Ohta et al. (1996) demonstrated that FHIT gene abnormalities often occur Introduction in primary digestive tract cancers. Considering that the highest frequency of allelic deleLung cancer is a major cause of mortality worldwide, and tions in lung cancer is on 3p and that tumors linked to the overall survival rate has not improved significantly in carcinogenic exposure could be especially susceptible the last 20 years. The understanding of the molecular to breakage at this site, we have analyzed a large series pathogenesis of this disease may help to prevent it and of lung cancers of the small cell and non-small cell type to provide new and more sensitive means to diagnose for alterations of the FHIT gene. and treat lung cancer patients.
The results indicate abnormalities of this gene in Alterations in oncogenes and tumor suppressor genes nearly all SCLCs and in a high proportion of NSCLCs, in small cell lung cancer (SCLC) and non-small cell lung suggesting a role for the FHIT gene in lung carcinocancer (NSCLC) have been described, the most frequent genesis. targets being alterations of p53 (Takahashi et al., 1989; Chiba et al., 1990; Mitsudomi et al., 1992) and retinoblastoma genes (Harbour et al., 1988; Xu et al., 1994) and Results allelic deletions of the short arm of chromosome 3 (3p) (Kok et al., 1987; Naylor et al., 1987; Rabbitts et al., RT-PCR and cDNA Sequence Analysis of SCLC To study abnormalities in FHIT transcripts from tumors 1989). In addition to cytogenetically visible deletions (Whang-Peng et al., 1982; Testa et al., 1994) , loss of and normal tissues, we reverse transcribed mRNAs and amplified the cDNAs by nested polymerase chain reacheterozygosity at loci on 3p has been reported in nearly 100% of SCLCs (Kok et al., 1987; Naylor et al., 1987;  tion (PCR) as described in Experimental Procedures. We studied 14 primary tumor samples and three cell Brauch et al., 1987; Yokota et al., 1987) and in 50% or more of NSCLCs (Brauch et al., 1987; Yokota et al., 1987;  lines (83L, H128, and U2020). In two cases, matched normal lung parenchyma was also analyzed. PCR), 11 (79%) showed the presence of abnormal transcripts ( Figure 1 ). Cell lines H128 and U2020 had a normal-sized product, whereas 83L presented two abnormal transcripts. Analysis of the amplified transcripts from the primary tumors consistently revealed two abnormal bands of ‫063ف‬ bp (type I) and ‫052ف‬ bp (type II). Seven cases displayed both type I and II abnormal transcripts, whereas four cases showed only the type I band. In two samples ( Figure 1A , case 107 and Figure  2A , case 45), as well as in the tumor-derived cell line ( Figure 2A , case 83L), the normal-sized transcript was undetectable, while in the other nine cases a normalsized band of varying intensity was observed. In one patient ( Figure 2A , case 83), we examined the primary tumor, a tumor-derived cell line, and a normal lung specimen. Whereas in the normal lung only the normal transcript was detected, the primary tumor ex- ysis with a painting probe of chromosome 3 showed the occurrence of several structural rearrangements of this chromosome, including a translocation of the 3p arm with a breakpoint in 3p14-3p21 (data not shown). Interobserved in the primary tumor reflected the presence of normal cells infiltrating the tumor specimen. estingly, in the cell line the normal-sized transcript was undetectable, suggesting that the normal-sized product Abnormal and normal-sized bands were separated on agarose gel, excised, and sequenced ( Figure 2B ). the tumor specimens. Cell line H128 displayed a normalsized transcript; however, sequence analysis revealed Sequence analysis of the aberrant bands revealed that the type I transcript corresponded to absence of exons a frameshift mutation, resulting from deletion of nucleotide 15 (Figure 4 ). 4 to 6 (nucleotides Ϫ111 to 249) of the published FHIT cDNA sequence (GenBank accession number U46922), Sequencing of the normal-sized RT-PCR product amplified from normal tissues (cases 45 and 83) revealed resulting in a junction between exons 3 and 7 of the FHIT cDNA. A loss of exons 4 to 8 (nucleotides Ϫ111 the presence of the wild-type FHIT transcript. to 348), resulting in fusion of exons 3 and 9, was found in the type II transcript. In each aberrant transcript the RT-PCR and cDNA Sequence Analysis of NSCLC RNA from 45 primary NSCLC tumors and matching norfusion junctions coincided with splice sites.
Since both types of aberrant transcripts lacked exon mal lung parenchyma samples were similarly studied; 18 of 45 tumors (40%) and the lung adenocarcinoma 5, which contains the initial methionine codon of the FHIT open reading frame (Ohta et al., 1996) , and type II cell line A549 displayed aberrant RT-PCR products. A detailed description of these results is summarized in transcripts also lacked nearly the entire coding region, including exon 8 containing the highly conserved HIT Table 1 . The RT-PCR-amplified products from the transcripts motif (Ohta et al., 1996) , it is likely that these aberrant fusion transcripts could not encode functional proteins. present in these tumors consisted of one or two abnormal bands, always accompanied by a normal-sized tranSequence analysis of the normal-sized bands revealed that they contained the normal FHIT cDNA, possiscript ( Figure 3A ). All the paired normal lung RNAs from the same lung cancer cases showed the presence of bly reflecting the contribution of normal cells infiltrating 
DNA and RNA from matched normal lung parenchyma and tumor tissue from 18 individuals were analyzed. Paired DNAs were tested for loss of microsatellite alleles (loss of heterozygosity) using markers spanning the FHIT locus; all but one of the informative tumor DNAs exhibited loss of a FHIT allele, as summarized in the column to the right, suggesting that the normal FHIT transcripts observed in some tumor RNAs (middle two columns) were derived from normal cells admixed with tumors. Cases shown are adenocarcinomas (ADC), squamous cell carcinomas (SQC), and a mucoepidermoid carcinoma (MUCOEp). Abbreviations: N, normal-sized transcript; A, abnormal transcript; NE, not evaluated; NI, not informative. a Loci analyzed were D3S1313, D3S1234, D3S4103 (ph13), D3S1300, and D3S1312. b In normal lung parenchyma, deletion of exon 3→9.
the normal FHIT product only, except one case (case 3 exons 4 and 8 or exons 4 and 9, respectively. All the types of abnormal transcripts observed lacked exon 5, in Table 1 ), which displayed an aberrant product differing in size from the aberrant product observed in the the first coding exon, and half (6 of 12) of the abnormal transcripts characterized by sequence analysis also corresponding tumor. Sequence analysis of the aberrant fragments revealed a range of RT-PCR products with showed loss of exon 8 containing the HIT domain. The normal-sized transcripts present in the tumors appeared losses of various exons from 4 to 9 (Table 1; Figure 3B ), including an RT-PCR product missing exons 4 to 8, normal by direct sequencing of the PCR product. However, in case 6, subcloning of the normal-sized product resulting in a junction of exons 3 and 9 (nucleotides Ϫ111 to 348), products missing exons 4 to 6 or 7, fusing disclosed the occurrence of three different clones: one with a normal sequence, one with an insertion of a 218 exon 3 to exon 7 or 8, respectively, and products missing exon 5 to exon 7 or 8, resulting in junctions between bp sequence with no significant homology to other genes, and a third clone missing exon 8 (nucleotides exon 5 (B4 and 76), exons 6 and 7 (05#1), and exon 8 (05#9) ( Figure 6A ). The results of these experiments are 280 to 348).
In cell line A549, the abnormal product showed loss shown in Figure 6B . BamHI digestion detected two fragments of about 23 kb and 15 kb, respectively, recognized of exon 4 and resulted in a splice site junction between exons 3 and 5.
by probe B4. The 15 kb fragment showed a polymorphism generating two smaller fragments of about 8 and Sequence analysis of the normal-sized transcript amplified from RNA of the normal tissue of these patients 6.5 kb in several cases ( Figure 6B , lanes 1 and 4). When probed with cosmid B4, the lung adenocarcinoma A549 revealed a normal FHIT cDNA sequence. A small alternatively spliced region at the beginning of exon 10 from cell line showed loss of both the 23 and 15 kb fragments and presented a rearranged band of about 18 kb (Figure nucleotides 450 to 460 (outside the open reading frame of the FHIT gene) was observed in the normal-sized 6B, lane 2), whereas a normal restriction profile was observed after hybridization with cosmid 76 ( Figure 6C , transcript present in the tumor and in the corresponding normal tissue of several patients.
lane 2), indicating a large deletion in intron 4. This finding is in keeping with the result of the RT-PCR analysis of FHIT transcripts in this cell line, which showed absence Southern Blot Analysis To characterize genomic alterations that might be reof exon 4 and a splice junction between exons 3 and 5 of the FHIT cDNA. In H128 DNA, hybridization with cosmid sponsible for production of the aberrant mRNA forms, we performed Southern blot analysis of DNAs from cell 05#1, covering a region of ‫04ف‬ kb encompassing exons 6 and 7, detected the absence of the largest band and lines and primary tumors. The FHIT cDNA does not exhibit internal BamHI restriction sites; thus, hybridization two abnormal restriction fragments of ‫32ف‬ kb and 18 of nearly full-length labeled FHIT cDNA to Southern blots of BamHI-cleaved cellular DNA should reveal a BamHI fragment for each of the ten FHIT exons, assuming a BamHI site in each intron. In fact, such hybridization revealed eight BamHI fragments, ranging in size from greater than 23 kb to 4 kb in normal cellular DNA (data not shown), as exemplified by the U2020 lane of Figure  5 . An altered cDNA hybridization pattern after BamHI cleavage would mean that a DNA alteration had occurred near a FHIT exon, i.e., within an exon-containing BamHI fragment. Digestion of DNAs with BamHI and hybridization with the full-length FHIT cDNA probe revealed abnormal restriction patterns in 4 out of 15 cases ( Figure 5 ). Tumors 111T and 104T lacked bands of 16 kb and 11 kb, respectively. The A549 cell line revealed loss of the 11 kb fragment and a rearrangement affecting a band of 17.5 kb, whereas in cell line H128 one fragment cosmids covering large intronic regions surrounding kb, indicating an alteration to both alleles in the vicinity been reported that microcell-mediated transfer of human chromosome 3 suppresses tumorigenicity of the of exons 6 and 7 ( Figure 6D) . A549 lung adenocarcinoma cell line (Satoh et al., 1993) . Deletions of 3p constitute particularly useful genetic Loss of Heterozygosity Analysis To look for allelic losses in tumor samples, a PCR-based markers, since several studies have reported that they occur in the early stages of lung carcinogenesis, such approach was used with primers that amplify polymorphic microsatellite markers internal to and flanking the as bronchial dysplasia and metaplasia (Sundaresan et al., 1992; Sozzi et al., 1991; Hung et al., 1995) . Moreover, FHIT gene. DNA from tumor and corresponding normal tissues from 28 NSCLC and 7 SCLC cases were analyzed it has been suggested that allelic loss on chromosome 3p in primary SCLC represents an unfavorable prognosfor allelic losses at loci D3S4103 (ph13) and D3S1300 internal to the FHIT gene (Ohta et al., 1996) and at loci tic factor (Horio et al., 1993) . This study describes the occurrence of abnormalities located in flanking regions, centromeric (D3S1312 at 3p14.2) (Druck et al., 1995) and telomeric (D3S1234 at in transcripts of the FHIT gene, located at 3p14.2, in at least 80% of SCLCs and 40% of NSCLCs, with 76% of 3p14.2 and D3S1313 at 3p14.3) to the FHIT gene (Kastury et al., 1996) (see Table 2 ).
the informative cases also exhibiting loss of one FHIT allele. Since the RT-PCR nested amplification would Loss of the D3S4103 and D3S1300 alleles, located in the intron between exons 5 and 6 of the FHIT gene detect only internal alterations in the FHIT gene transcripts, this is a conservative estimate of the frequency ( Figure 5A ), was found in 19 of 25 (76%) and 11 of 12 (92%) informative cases for the two loci, respectively.
of FHIT gene alteration in SCLC and NSCLC. The aberrant lung tumor transcripts were missing two At the D3S1312 and D3S1313 loci, 12 of 19 (63%) and 9 of 13 (69%) tumors, respectively, also showed loss of or more exons of the FHIT gene. While in NSCLCs a varying pattern of abnormal transcripts was detected, heterozygosity, indicating a large deletion in this genomic region. Overall, 11 of 12 (92%) of the informative in SCLCs the amplified transcripts were either missing exons 4 to 6 or exons 4 to 8. Both types result in loss tumors (9 of 10 NSCLC and 2 of 2 SCLC) that exhibited abnormal FHIT transcripts showed allelic losses at one of exon 5, containing the initial methionine codon (Ohta et al., 1996) , with the second type also showing loss of or more of the loci tested. exon 8 containing the highly conserved HIT domain (Ohta et al., 1996) .
Discussion
Two cases of primary SCLC and a tumor cell line lacked the normal-sized transcript, which was also unThree distinct chromosomal regions of 3p, which include 3p25, 3p21.3-3p21.2, and 3p12-3p14.1, are believed to derrepresented in the remaining cases. In addition, one primary tumor exhibited a normal and two abnormal harbor a gene(s) involved in lung cancer on the basis of the high frequency of allelic loss in primary tumors and transcripts, while a normal-sized product was not amplified from the cell line established from this tumor. These defined homozygous deletions in lung cancer-derived cell lines; extensive efforts have been made to define observations suggest that in the SCLC RNA the wildtype transcript could have derived from admixed normal small, common regions of loss to isolate tumor suppressor genes in these chromosomal regions. It has also cells. Microsatellite loci flanking (D3S1313 and D3S1312), within (D3S4103 and D3S1300), or near the FHIT gene (D3S1234, between D3S1313 and D3S4103, but exact position relative to the telomeric side of the FHIT gene is unknown) were tested for loss in SCLC and NSCLC DNAs for which matched normal DNA was available. The number of tumor DNAs with loss, divided by the number informative, is shown under each microsatellite marker. Results for all tumors are combined; note that the highest frequency of loss was observed at the D3S1300 locus, which is within intron 5 of the FHIT gene.
In RNAs from NSCLCs, the abnormal RT-PCR-amplirearrangements likely occur in the large intronic regions of the FHIT gene. Although the exact molecular mechafied products were less abundant than the normal-sized RT-PCR-amplified products. However, the apparently nisms by which these genomic rearrangements generate abnormal transcripts are still to be elucidated, these normal-sized transcripts could consist of a mixture of cell clones carrying small alterations not visible as disobservations suggest that aberrant FHIT genes are the result of DNA rearrangements, particularly in the region crete bands in agarose gel. Accordingly, subcloning of the normal-sized product in one NSCLC (case 6) renear exon 5. The high frequency (76%) of loss of one FHIT allele vealed, besides the normal FHIT product, the presence of two different clones, one with a deletion in exon 8 observed in lung tumors of both small cell and non-small cell type is noteworthy. In addition, the microsatellite and the other with an insertion of 218 bp downstream of exon 4. The abundance of normal-sized product in marker D3S1300, which maps close to the first coding exon (exon 5), detected the highest frequency of allelic NSCLC could also be related to the heterogeneous, often multifocal nature of these neoplasms, which arise deletions (92%). Although we did not determine a minimal region of loss in our cases, these findings support as a consequence of the chronic exposure of the entire bronchial "field" to carcinogens, resulting in the presthe idea that inactivation of the FHIT gene could have occurred by a mechanism of loss of one allele and alence of different cell clones carrying different genetic changes (Kim et al., 1993; Barsky et al., 1994 ; Ebina tered expression of the remaining one. This model is consistent with the observation that et al., 1994). In addition, the tumor samples contained variable amounts of normal stromal tissue (stromal infilthe FHIT gene spans a common fragile region, FRA3B, where abnormalities such as deletions could be more tration is known to occur in non-small cell tumors; Rabbitts et al., 1989) . The complete allele loss seen in the frequent than point mutations. Tumors associated with carcinogen exposure, such as cancers of the aerodiges-SCLC cell line and several SCLC primary specimens and the lack of complete allele loss in NSCLC supports this tive tract, could be particularly susceptible to alterations of the FHIT gene. Owing to its etiology, lung cancer is interpretation. It is also possible that the abnormal transcripts are less stable than the wild-type product.
likely to be strongly and directly associated with the effects of agents that interfere with DNA replication, In cell line H128, sequencing of the RT-PCR FHIT product revealed a frameshift mutation resulting from a such as agents in tobacco smoke. Breakage in a fragile site-containing gene as a consequence of physical, deletion of nucleotide 15 (exon 5). This finding represents evidence of a point mutation in the coding sechemical, and biological agents can thus be expected. Expressivity of the FRA3B fragile site in peripheral blood quence of FHIT; thus, in the SCLC-derived H128 cells, perhaps one FHIT allele is silent as a consequence of lymphocytes of patients with cancer has been investigated; the expression of FRA3B appeared to be influthe genomic rearrangement that occurred in the region covered by cosmid 05#1, encompassing exons 6 and enced by habitual tobacco smoking, and significantly higher expression was reported in lung cancer patients 7, and the other allele is mutated in the coding sequence.
In the normal tissue of the patients showing abnormal . Of particular interest was one NSCLC patient (case 3 of Table 1 ) with a mucoepidertumor transcripts, we have observed a normal FHIT product by PCR and sequence analysis. moid carcinoma of the lung who subsequently developed a renal cell carcinoma. In the normal lung parenOwing to the structural organization of FHIT, which is composed of ten small exons distributed over at least chyma of this patient, an abnormal transcript missing exons 4 to 8 was detected. This finding raises the possi-500 kb, genomic rearrangements could best be observed by using an infrequently cutting enzyme such as bility that a constitutional alteration within the FHIT gene could be associated with a predisposition to develop BamHI. Hybridization with specific cosmids covering intronic and exonic regions revealed altered restriction both lung and renal cancer or other types of multiple primary tumors. However, this alteration could have patterns in some cell lines and tumor DNA. Of particular interest is the finding of a deletion and a rearranged band been somatically acquired, because carcinogen exposure can induce transformation in several fields of the occurring in the fragile site region covered by cosmid B4 (Ohta et al., 1996) (Sambrook et al., 1989) . Analysis of allelic losses of digestive tract cancer and lung cancer. It has also was performed using a PCR-based approach. Primers that amplify been proposed that Ap 4 A may mediate adaptive repolymorphic microsatellite markers were used for the following loci: D3S4103 (ph13) and D3S1300 internal to the FHIT gene (Ohta et al., sponses of mammalian cells to environmental stress, (Ohta et al., 1996) . Hybridization probes were prepared by ranmous cell carcinomas, 1 mucoepidermoid carcinoma, and 14 small dom primer extension (Stratagene). Unincorporated nucleotides cell lung carcinomas, were obtained from surgically resected lung were removed by spin filtration in G-50 columns. The preannealing cancer patients at Istituto Nazionale Tumori (Milan, Italy). A lung reaction consisted of 100 ng/ml of probe, 0.5ϫ SSC, and 0.5 mg/ adenocarcinoma cell line (A549) and three small cell lung carcinoma ml sheared human genomic DNA. After heating the mixture at 100ЊC cell lines (H128, U2020, and 83L) were also analyzed. Cell line 83L
for 10 min, we incubated it at 65ЊC for 2 hr. The probe was added was established from small cell tumor, 83T. Among NSCLCs, 29 to the prehybridized filters at 5 ϫ 10 6 to 6 ϫ 10 6 cpm per milliliter were in stage I, 9 were in stage II, and 6 were in stage III. The tumors of hybridization solution consisting of 5ϫ SSPE, 5ϫ Denhardt's were classified histologically according to the Histological Typing solution, 0.1% SDS, 0.1 mg/ml single-stranded DNA, and 0.5 mg/ of Lung Tumors by the World Health Organization (1987) and staged ml sheared human genomic DNA. according to the TNM classification of malignant tumors defined by the International Union Against Cancer (1987) . Most cases (54 out Acknowledgments of 59) were from male patients, and the mean age of cases at presentation was 63 years. Matched normal lung parenchyma tissue Correspondence should be addressed to C. M. C. This work was samples were taken at a most distant site from the tumor or in a supported by the National Cancer Institute (NCI) Outstanding Invesdifferent segment or lobe as a source for the normal RNA and DNA.
tigator grant CA39860 to C. M. C., grant PO1CA21124, and NCI Cancer Center grant CA56336 to the Kimmel Cancer Center; by a RNA Extraction and RT gift of R. R. M. Carpenter, III and M. K. Carpenter; and by grants Tumor and normal specimens were frozen immediately after surgical from the Associazione Italiana Ricerca Cancro and the Consiglio resection and stored at Ϫ80ЊC. Total mRNA was extracted from Nazionale delle Ricerche Special Project ACRO and an AIDS fellowfrozen tumor and normal lung tissues using guanidinium-LiCl sepaship (2601/SAP 7.2) from the Istituto Superiore di Sanita' Italy (to ration (Sambrook et al., 1989) or the RNA-STAT kit (Tel TEST). cDNA M. L. V.). We thank Patrizia Mondini for expert technical assistance. was synthesized from 1 g of total RNA. RT was performed in a 20 l volume of 1ϫ first strand buffer (GIBCO), 10 mM DTT (GIBCO), Received February 20, 1996; revised March 11, 1996 . 500 M dNTPs, 50 ng/l oligo(dT), 0.3 g/l random primers, 16.5 U of RNAsin (Promega), and 300 U of Superscript II (GIBCO). The samples were first denatured for 5 min at 95ЊC and then incubated References at 37ЊC for 60 min. The reaction was stopped by inactivating the Baker, J.C., and Jacobson, M.K. (1986) . Alteration of adenyl dinucleenzyme at 94ЊC for 5 min. The reaction was diluted to 30 l, and 1 otide metabolism by environmental stress. Proc. Natl. Acad. Sci. l was used for subsequent PCR amplification.
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